Search Results

AviadoBio today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open and recruiting patients in the United States at The Ohio State University.

PAVmed Inc announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, launched a pilot program and enrolled the first patients on the Veris Cancer Care Platform™ pursuant to a recently-executed memorandum of understanding.

PAVmed Inc. announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, have executed a memorandum of understanding to implement a pilot program where cancer patients would be enrolled on the Veris Cancer Care Platform™.

Bruker Corporation announced the successful installation of a 1.2 Gigahertz NMR system at the National Gateway Ultrahigh Field NMR Center at The Ohio State University.

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced that it will celebrate the opening of its Axogen Processing Center with leaders of the Ohio community on June 12, 2024.

The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.

Springfield Regional Outpatient Surgery Center, a joint venture between Bon Secours Mercy Health, Compass Surgical Partners, and local physicians, announced the opening of its new 12,000-square-foot ambulatory surgery center in Springfield, Ohio.

BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF) (5LB: FRA) (“BioVaxys” or “the Company”), is pleased to announce that it has further extended its research collaboration with The Ohio State University (“The Ohio State”) for SARS-CoV-2, SARS-CoV-1, and pan-sarbecovirus vaccine research.

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization, is collaborating with The Ohio State University Gene Therapy Institute for the development and clinical manufacturing of novel gene therapies.

Heart Hospital of New Mexico at Lovelace Medical Center and GE HealthCare announced HHNM as the first location in the United States to install GE HealthCare’s latest Allia Image Guided System Pulse, which was designed to provide exceptional image quality and improve workflow for the diagnosis and treatment of cardiovascular diseases.